Us Human Rabies Vaccination Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Human Rabies Vaccination Market was valued at USD 0.50 Billion in 2022 and is projected to reach USD 0.80 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030.
The U.S. human rabies vaccination market is experiencing significant growth, driven by increasing awareness of rabies prevention and rising vaccination initiatives. In 2024, the market was valued at approximately $0.62 billion and is projected to reach $1.23 billion by 2034, reflecting a compound annual growth rate (CAGR) of around 6.98% during this period. This growth is attributed to several key factors:
Increasing Incidence of Rabies: Rabies remains a fatal viral disease transmitted through the bite of an infected animal, most commonly dogs. The World Health Organization (WHO) estimates that rabies causes approximately 59,000 deaths each year, primarily in Asia and Africa. The rising number of rabies cases is due to several factors, including the growing population of stray dogs, the lack of access to rabies vaccination in some regions, and the increasing movement of people and animals across borders. As the incidence of rabies continues to rise, the demand for human rabies vaccines is expected to grow.
Growing Awareness of Rabies Prevention: Public health campaigns and educational programs have helped to raise awareness of the importance of rabies vaccination. As more people become aware of the risks of rabies and the benefits of vaccination, the demand for human rabies vaccines is expected to increase.
Government Initiatives to Control Rabies: Many governments have implemented mandatory rabies vaccination programs for dogs and other animals. These programs have helped to reduce the incidence of rabies in some regions. However, rabies remains a major problem in many developing countries, where access to rabies vaccination is limited. As governments continue to implement rabies control programs, the demand for human rabies vaccines is expected to increase in these regions.
The market is segmented based on vaccine type into killed virus vaccine, modified live virus vaccine, and recombinant vaccine. The killed virus vaccine segment held the largest share of the Human Rabies Vaccine Market in 2023 due to its widespread use and high efficacy. However, the modified live virus vaccine segment is expected to grow at a faster CAGR during the forecast period due to its increased effectiveness and lower risk of side effects. The recombinant vaccine segment is also expected to grow at a significant CAGR during the forecast period due to its high efficacy and low risk of side effects.
Overall, the Human Rabies Vaccine Market is expected to grow at a steady pace during the forecast period, driven by the increasing demand for rabies vaccines in developing countries and the development of new and more effective vaccines.
Get an In-Depth Research Analysis of the Global Human Rabies Vaccination Market Size And Forecast [2025-2032]
Â
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Human Rabies Vaccination Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Human Rabies Vaccination Market
Inactivated Rabies Vaccines
Live Attenuated Rabies Vaccines
Recombinant Rabies Vaccines
DNA-based Vaccines
Intramuscular Injection
Subcutaneous Injection
Intradermal Injection
Oral Administration
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Post-exposure Management in Animal Bites
Occupational Exposure (e.g., veterinary, laboratory workers)
Travel-related Prophylaxis
Hospitals
Ambulatory Surgical Centers
Vaccination Clinics
Research Laboratories
Pharmaceutical Companies
Direct Distribution
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Healthcare Institutions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Human Rabies Vaccination Market Research Analysis
1. Introduction of the Global Human Rabies Vaccination Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Human Rabies Vaccination Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Human Rabies Vaccination Market, By Type
6. Global Human Rabies Vaccination Market, By Application
7. Global Human Rabies Vaccination Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Human Rabies Vaccination Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/